Guizhou Bailing Group Pharmaceutical Co., Ltd. (SHE:002424)
5.35
-0.04 (-0.74%)
Jul 22, 2025, 1:45 PM CST
Guizhou Bailing Group Pharmaceutical Company Description
Guizhou Bailing Group Pharmaceutical Co., Ltd. research, develops, produces, and sells medicines in China.
The company provides medicines in the form of tablets, capsules, granules, syrups, powders, pills, tinctures, sprays, lotions, and cream for cardiovascular and cerebrovascular diseases, cough, cold, pediatric, and gynecologic diseases.
Guizhou Bailing Group Pharmaceutical Co., Ltd. was founded in 1999 and is headquartered in Anshun, China.
Guizhou Bailing Group Pharmaceutical Co., Ltd.
Country | China |
Founded | 1999 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 6,586 |
CEO | Min Niu |
Contact Details
Address: No. 212, Xihang Road Anshun, 561000 China | |
Phone | 86 851 3341 1018 |
Website | gzbl.com |
Stock Details
Ticker Symbol | 002424 |
Exchange | Shenzhen Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | CNY |
ISIN Number | CNE100000PY3 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Wei Jiang | Acting Secretary of the Board of Directors and Chairman |
Min Niu | GM and Director |
Hongxing Li | Chief Financial Officer |
Pei Chen | Deputy GM and Director |
Yuan Zhen Yuan | Executive Vice President |
Yong Jiang | Director |
Zhining Wu | Accounting Supervisor |